Pfizer (PFE) Granted Six Months Pediatric Exclusivity for LYRICA

November 27, 2018 3:02 PM
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for LYRICA® ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles